
RosemaryBoyton
@boytonrosemary
Professor of Immunology and Respiratory Medicine, opinions my own
ID: 1341827147078483968
23-12-2020 19:25:13
303 Tweet
580 Followers
215 Following

Work by RosemaryBoyton @Daltmann10 & colleagues forecasted the BA.5 bivalent response. Either booster (WT or bivalent) will help preserve high level of protection vs severe Covid But the lack of inducing big ⬆️in nAbs to BA.5 from the bivalent supports imprinting, short🧵

Deena Heg Eric Topol RosemaryBoyton @Daltmann10 x.com/erictopol/stat…

Delighted for this prestigious AACR recognition Surgery and Cancer UPO - Università Alessandra Gennari MD PhD

New CLARITY IBD findings 👇 ❗to continue SARS-CoV-2 vaccination programmes, inc. second-generation bivalent vaccines. Esp when vaccine immunogenicity and efficacy might be reduced, such as those on anti-TNF therapies. Great work, thank you 👏👏👏 #ibdpatients Be Part of Research

Great to see this work out! Lots of hard work from Dragana Milojkovic and RosemaryBoyton’s teams Imperial Department of Immunology & Inflammation Imperial Medicine Imperial NHS 💙 Malignant Haematology CTU Imperial nature.com/articles/s4137… 1/3


A new study led by RosemaryBoyton Imperial College London has found that immune responses to the #COVID19 #vaccine in people with chronic myeloid #leukaemia, treated with tyrosine kinase inhibitors, are similar to those in people without the illness. #CML covidvaccineresearch.org/news/covid-19-…



That's RosemaryBoyton who has done some of the most important work to illuminate Covid imprinting


Combination immunotherapy (PD-1/VEGF and PD-1/CTLA-4) leads to superior survival in advanced #HCC - thanks to Claudia Angela M. Fulgenzi for shedding light on 1L treatment decisions in #HCC ILCA EASLnews EASL Education ASCO ESMO - Eur. Oncology Imperial Hepatology NIHR Imperial BRC ✨🌈 jhep-reports.eu/article/S2589-…

Honoured to have been tasked to write this Journal of Clinical Oncology Editorial on Antibiotic Therapy💊: The Cornerstone of Iatrogenic Resistance to Immune Checkpoint Inhibitors 🔥 Alessio Cortellini Surgery and Cancer Imperial NHS 💙 UPO - Università 🧑🔬 ascopubs.org/doi/10.1200/JC…




Our RosemaryBoyton, co-lead investigator of this research said: "A simple intervention like interrupting methotrexate for two weeks immediately after the COVID-19 booster vaccine dose improved subsequent antibody responses and that this effect was sustained at 26 weeks."


Did you know early onset #Type2Diabetes is on the rise? To mark #DiabetesAwarenessWeek, Dr Shivani Misra from Metabolism, Digestion & Reproduction sheds light on her research which aims to tackle early onset type 2 diabetes in our latest blog. 👇 blogs.imperial.ac.uk/imperial-medic…